Výsledky vyhledávání - Bruno Scherrer
- Zobrazuji výsledky 1 - 7 z 7
-
1
-
2
-
3
A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepat... Autor Francque Sven M., Bedossa Pierre, Abdelmalek Manal F., Anstee Quentin M., Elisabetta Bugianesi, Vlad Ratziu, Philippe Huot-Marchand, Bruno Scherrer, Jean-Louis Junien, Pierre Broqua, Jean‐Louis Abitbol
Vydáno 2020Artigo -
4
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial Autor Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau, Olaf Valverde Mordt, Séverine Blesson, François Simon, Sophie Delhomme, Sonja Bernhard, Willy Kuziena, Jean-Pierre Fina Lubaki, Steven Lumeya Vuvu, Pathou Nganzobo Ngima, Hélène Mahenzi Mbembo, Médard Ilunga, Augustin Kasongo Bonama, Josué Amici Heradi, Jean Louis Lumaliza Solomo, Guylain Mandula, Lewis Kaninda Badibabi, Francis Regongbenga Dama, Papy Kavunga Lukula, Digas Ngolo Tete, Crispin Lumbala, Bruno Scherrer, Nathalie Strub‐Wourgaft, Antoine Tarral
Vydáno 2017Artigo -
5
Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study Autor Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau, Olaf Valverde Mordt, Digas Ngolo Tete, Séverine Blesson, François Simon, Sophie Delhomme, Sonja Bernhard, Hélène Mahenzi Mbembo, Christian Mpia Moke, Steven Lumeya Vuvu, Junior Mudji E'kitiak, Felix Akwaso Masa, Melchias Mukendi Ilunga, Dieudonné Mpoyi Muamba Nzambi, Tim Mayala Malu, Serge Kapongo Tshilumbwa, Franck Botalema Bolengi, Mathieu Nkieri Matsho, Crispin Lumbala, Bruno Scherrer, Nathalie Strub‐Wourgaft, Antoine Tarral
Vydáno 2021Artigo -
6
Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial Autor Victor Kande Betu Kumeso, Wilfried Mutombo Kalonji, Sandra Rembry, Olaf Valverde Mordt, Digas Ngolo Tete, Adeline Prêtre, Sophie Delhomme, Médard Ilunga Wa Kyhi, Mamadou Camara, Julie Catusse, Stefan Schneitter, Morgane Nusbaumer, Erick Mwamba Miaka, Hélène Mahenzi Mbembo, Joseph Makaya Mayawula, Mariame Camara, Félix Akwaso Massa, Lewis Kaninda Badibabi, Augustin Kasongo Bonama, Papy Kavunga Lukula, Sylvain Mutanda Kalonji, Phyll Mariero Philemon, Ricardo Mokilifi Nganyonyi, Hugues Embana Mankiara, André Asuka Akongo Nguba, Vincent Kobo Muanza, Ernest Mulenge Nasandhel, Aimée Fifi Nzeza Bambuwu, Bruno Scherrer, Nathalie Strub‐Wourgaft, Antoine Tarral
Vydáno 2022Artigo -
7
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial Autor Enrico Bertini, Éric Dessaud, Eugenio Mercuri, Francesco Muntoni, Janbernd Kirschner, Carol Reid, Anna Łusakowska, Giacomo P. Comi, Jean-Marie Cuisset, Jean‐Louis Abitbol, Bruno Scherrer, Patricia Sanwald Ducray, J. Buchbjerg, Eduardo Vianna, W. Ludo van der Pol, Carole Vuillerot, Thomas Blaettler, Paulo Fontoura, Carole André, Claudio Bruno, B. Chabrol, Nicolas Deconinck, B. Estournet, S. Fontaine-Carbonnel, Nathalie Goemans, Ksenija Gorni, Alessandra Govoni, Michela Guglieri, Hanns Lochmüller, Francesca Magri, M. Mayer, Wolfgang Müller‐Felber, François Rivier, Helen Roper, Ulrike Schara, Mariacristina Scoto, Leonard van den Berg, Giuseppe Vita, Maggie C. Walter
Vydáno 2017Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Pediatrics
African trypanosomiasis
Alternative medicine
Disease
Immunology
Pathology
Placebo
Trypanosomiasis
Adverse effect
Biochemistry
Biology
Clinical trial
Computer science
Environmental health
Physical therapy
Population
Surgery
Abdominal pain
Agonist
Ambulatory
Anesthesia
Barostat
Cerebrospinal fluid
Clinical endpoint
Cohort
Combinatorics
Crossover study
Double blind